Cigna Group (NYSE:CI) Downgraded to Outperform Rating by Raymond James Financial

Cigna Group (NYSE:CI) was downgraded by equities research analysts at Raymond James Financial from a “strong-buy” rating to an “outperform” rating in a research report issued to clients and investors on Monday, Marketbeat reports. They presently have a $320.00 price target on the health services provider’s stock. Raymond James Financial’s target price would suggest a potential upside of 14.58% from the stock’s current price.

Other equities analysts have also recently issued research reports about the company. Piper Sandler cut their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. UBS Group raised their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Barclays lifted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday. Finally, The Goldman Sachs Group increased their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $340.60.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $279.27 on Monday. The stock’s fifty day simple moving average is $286.62 and its 200 day simple moving average is $281.14. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $73.79 billion, a PE ratio of 11.55, a PEG ratio of 1.07 and a beta of 0.29. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period in the previous year, the firm earned $7.20 earnings per share. The company’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, research analysts predict that Cigna Group will post 30.5 EPS for the current year.

Insider Buying and Selling

In other news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Hedge funds have recently modified their holdings of the stock. Evercore Wealth Management LLC increased its position in shares of Cigna Group by 2.8% during the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after purchasing an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Cigna Group by 11.0% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after buying an additional 36 shares during the last quarter. OLD National Bancorp IN grew its stake in shares of Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after buying an additional 37 shares in the last quarter. IHT Wealth Management LLC grew its stake in shares of Cigna Group by 2.5% in the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after buying an additional 38 shares in the last quarter. Finally, Whetstone Capital Advisors LLC increased its holdings in Cigna Group by 4.9% during the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after buying an additional 39 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.